Carregant...
The role of microRNA in the resistance to treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death with a limited efficacy of treatment for intermediate and advanced stages of the disease. Several therapeutic approaches such as trans-arterial chemoembolization (TACE) with anthracyclines, cisplatin and multikina...
Guardat en:
| Publicat a: | Ann Transl Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6861820/ https://ncbi.nlm.nih.gov/pubmed/31807558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.09.142 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|